Moderna

American biotechnology company
Organization Business Q17081612

Facts

26 properties

Identity

Instance of
business, public company, biopharmaceutical company[4][5]
Official website
www.modernatx.com[16]
Official name
Moderna, Inc.[28]

Status and dates

Inception
2010, July 22, 2016[14][15]
⚖ sources disagree Wikidata 2010 · 2016-07-22 ROR 2014 edition 2026-09-26 · cc0-1.0+geonames-cc-by-4.0 ↗

Location

Headquarters location
Cambridge[9]
Located in the administrative territorial entity
Cambridge[2]as of 2026-10-21
where from?
Edition
20261021 · as of 2026-10-21
Bronze
7a7bf58d5ac18436 v2.15-2026-10-20-ror-data.zip
Transform
4ort-mint · ror:20261021 · version not recorded

Industry and activity

Field of work
RNA vaccine[1]
Product or material produced
medication[18]

Financials

Employees
5.8k (680–5.8k, n=8)[19][20][21][22][23][24][25][26]
Net profit
-3.6B (-4.7B–12.2B, n=9)[44][45][46][47][48][49][50][51][52]
Operating income
9.4B (-763.0M–13.3B, n=7)
Total assets
1.4B (1.1B–2.0B, n=4)[53][54][55][56]
Total equity
-334.8M (-551.4M–1.5B, n=4)[30][31][32][33]
Total revenue
3.2B (60.2M–19.3B, n=9)[34][35][36][37][38][39][40][41][42]

People

Chief executive officer
Stéphane Bancel (2011–present)[10]
Board member
Stéphane Bancel (2011–present), Tal Zaks (2015–present), Noubar Afeyan (2012–present), Robert S. Langer, Jr. (2010–present), Elizabeth Nabel (2015–present), Israel Ruiz (2017–present), Paul Sagan (2018–present), Moncef Slaoui (2017–present)[57][58][59][60][61]
Director / manager
Stéphane Bancel[17]

Relations

More facts +5
Date of first performance
February 18, 2026[27]
Estimated value
3,000,000,000 USD (2016)
Market capitalization
9,456,000,000 USD (2025)[43]
Social media followers
12k (5.0k–152k, n=6)
Stock exchange
Nasdaq (2018–present)[11]
🏷️ Also known as
en Moderna, Inc. en Moderna Therapeutics, Inc. en Moderna Therapeutics en Moderna ar موديرنا da Moderna Therapeutics da Moderna, Inc. es Moderna Inc. es Moderna, Inc. fa مدرنا fr Moderna Therapeutics he מודרנה ja モデルナ ko 모더나 nl Farmaceut Moderna ro Moderna, Inc. ro Moderna Therapeutics ro Moderna Therapeutics, Inc. zh 摩德纳 zh 莫德納
🔖 Identifiers · 31
ROR ID
01xm4wg91
Legal Entity Identifier
549300EI6OKH5K5Q2G38
GRID ID
grid.479574.c
Article ID in the Lithuanian Universal Encyclopedia Online
moderna
BBC News topic ID
c8grzynv1mgt
Bloomberg company ID
MRNA:US
Central Index Key
0001682852
Crunchbase organization ID
moderna-therapeutics
Delaware Division of Corporations file number
6104873
Show all 31 identifiers +19
Described at URL
apnews.com
EU Transparency Register ID
011080341579-06
Facebook username
modernatx
Freebase ID
/m/0w2ztxm
Golden ID (archived)
Moderna_Therapeutics-EY4K96
IRS Employer Identification Number
81-3467528
Open Funder Registry funder ID
100019533as of 2026-10-21
where from?
Edition
20261021 · as of 2026-10-21
Bronze
7a7bf58d5ac18436 v2.15-2026-10-20-ror-data.zip
Transform
4ort-mint · ror:20261021 · version not recorded
OpenCorporates organization ID
us_de/6104873
Press information URL
www.modernatx.com
Quora topic ID
Moderna-Therapeutics
Ringgold ID
380888
Scilit organization ID
69783
UK Parliament thesaurus ID
479919
WikiKids ID
Moderna
X (Twitter) username
moderna_tx (2013–present)
YouTube channel ID
UChCzhLMQnwF1w-_J8q1IpPA (2011–present)
📚 Sources · 2

Report an error or request removal Lineage (PROV-JSON)

📈 SEC EDGAR
Public · NYSE/NASDAQ
CIK 0001682852
View SEC filings →
⛏️ Lake Facts · open-dataset statements via 4ort-mint

From open datasets, joined by identifier and shown only for properties Wikidata does not state on this entity — except where the dataset is the registry authority for the fact (ClinicalTrials.gov on trial registration data): there its value is shown instead, with Wikidata's noted beside it. Every row carries its dataset edition and licence.

OpenAlex IDP10283
I4210108601 2026-09-27 OpenAlex (CC0 1.0) as of 2026-09-27
where from?
Source
OpenAlex
Edition
20260927 · as of 2026-09-27
Licence
CC0 1.0
Credit
CC0 1.0 (OpenAlex snapshot, openalex.org). Values as shipped.
Bronze
not in the catalog
Transform
4ort-mint · lake · version not recorded
CC0 1.0 (OpenAlex snapshot, openalex.org). Values as shipped.
⚖️ Sworn Facts · SEC filings
subsidiary · 28filed
Moderna Australia Pty Ltd sec.gov ↗
Moderna Biopharma Canada Corporation sec.gov ↗
Moderna Biotech Distributor UK Ltd. sec.gov ↗
Moderna Biotech Manufacturing UK Ltd. sec.gov ↗
Moderna Biotech Securities, Inc. sec.gov ↗
Moderna Biotech Singapore Pte. Ltd. sec.gov ↗
Moderna Biotech Spain, S.L.U. sec.gov ↗
Moderna Biotech UK Limited sec.gov ↗
Moderna Charitable Foundation, Inc. sec.gov ↗
Moderna Clinical Supply Distributor, LLC sec.gov ↗
Moderna Enzymatics Co., Ltd. sec.gov ↗
Moderna France sec.gov ↗
Moderna Germany GmbH sec.gov ↗
Moderna Hong Kong Limited sec.gov ↗
Moderna Italy S.r.l. sec.gov ↗
Moderna Japan Co., Ltd. sec.gov ↗
Moderna Korea Limited sec.gov ↗
Moderna Manufacturing Australia Pty Ltd. sec.gov ↗
Moderna Manufacturing Canada Corp. sec.gov ↗
Moderna Netherlands B.V. sec.gov ↗
Moderna Norway AS sec.gov ↗
Moderna Norwood Real Estate LLC sec.gov ↗
Moderna Poland sp. z o.o. sec.gov ↗
Moderna Services, Inc. sec.gov ↗
Moderna Sweden AB sec.gov ↗
+3 more in the filed exhibit
Structured parse of sworn SEC fields only. Facts a model extracted from 8-K narrative text are not shown here — how we measure this.
🔗 Connections
Board member 4
Owns / has subsidiaries 4
Employees / affiliates 3
Owned by 3
Industry 2
Instance of 2
← Ultimate parent organization 2
Chief executive officer 1
Country 1
Director / manager 1
Field of work 1
Headquarters location 1
Legal form 1
Product or material produced 1
Stock exchange 1
← Affiliation 1
← Developer 1
← Manufacturer 1
Press Enter · cited answer in seconds

Financials

Self-reported XBRL data from 10 annual filings
Revenue
$1.94B
▼ 39.9% YoY FY2025
Net Income
-$2.82B
▲ 20.8% YoY FY2025
Assets
$12.34B
▼ 12.8% YoY FY2025
EPS (diluted)
$-7.26
▲ 21.8% YoY FY2025
$0.00$5.30B$10.59B$15.89B$21.19B FY2016: $108.40M · NI -$216.21M (-199.5% margin)FY2017: $205.82M · NI -$255.92M (-124.3% margin)FY2018: $135.07M · NI -$384.73M (-284.8% margin)FY2019: $60.21M · NI -$514.00M (-853.7% margin)FY2020: $803.00M · NI -$747.00M (-93.0% margin)FY2021: $18.47B · NI $12.20B (66.1% margin)FY2022: $19.26B · NI $8.36B (43.4% margin)FY2023: $6.85B · NI -$4.71B (-68.8% margin)FY2024: $3.24B · NI -$3.56B (-110.0% margin)FY2025: $1.94B · NI -$2.82B (-145.2% margin) '16'17'18'19'20'21'22'23'24'25
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession 0001682852-26-000033
🛰️ Living Edge · news-derived, source-cited

high ≥ 0.90 · emerging ≥ 0.65 · low below — calibrated against hand-rated truth (single-source .44 · two-source .62 · production-typical .70), so a band is a measurement, not a promise. High is rare by design: it needs both a supported assertion and an evidence sentence. A confirmed or contradicted chip is a Wikidata cross-check; no chip means Wikidata has no value for that property — the ordinary case here, and it says nothing either way. A confirm-only note marks a property whose check can never disagree (Wikidata's border and capital data is not exhaustive), so silence there is a limit of the check, not of the claim.

partner 4ort Merck high0.9722 independent sources

evidence “Developments in tackling cancer—such as the encouraging results of an mRNA cancer vaccine that were announced by Moderna and Merck last month—stem from “decades of progress, decades of new knowledge, decades of even failure, and learning from that failure to bring forth these kinds of results,” Jacobson said.” time.com · read source

competitor 4ort Pfizer high0.9110 independent sources

evidence “Moderna's vaccine is approved for ages six months and older, while Pfizer's shot can be given to people over the age of five.” dailymail.com · read source

Stock exchange Nasdaq emerging0.868 independent sources

evidence “It was Moderna's (NASDAQ:” aol.com · read source

competitor 4ort Biontech emerging0.866 independent sources

evidence “BioNTech and Moderna may have bright futures as they advance their vaccine candidates.” fool.com · read source

Industry pharmaceutical emerging0.857 independent sources

evidence “The information we have on clinical trial results comes courtesy of pharmaceutical companies Moderna and Merck and hasn’t been officially published yet.” womenshealthmag.com · read source

Industry biotech emerging0.805 independent sources

evidence “Moderna is still an unprofitable biotech burning cash, with FY 2025 revenue of $1.94 billion, down 40% year over year, and 2026 guidance calling for year-end cash of $4.7 billion to $5.2 billion, down from $8.1 billion.” finance.yahoo.com · 2026-09-16 · read source

Industry biotechnology emerging0.764 independent sources

evidence “Moderna (MRNA) lit up the biotechnology sector at a pace not seen since the COVID pandemic.” baystreet.ca · read source

Industry oncology emerging0.764 independent sources

evidence “Second, while by all means a likely game changer for Moderna, commercialization of these oncology MRNA products remains years away.” fool.com · read source

Member of S&P 500 emerging0.722 independent sources

evidence “Moderna led the S&P 500 in August after reporting promising results from a late-stage trial of a personalized mRNA cancer vaccine it co-developed with Merck, according to CNBC.” finance.yahoo.com · read source

Headquarters location Cambridge emerging0.703 independent sources

evidence “Now working at pharmaceutical company Moderna in Cambridge, Massachusetts, she uses AI to improve manufacturing processes by working out the most promising parameters of an experiment and identifying areas for further investigation.” nature.com · read source

Ticker symbol MRNA emerging0.703 independent sources

evidence “The basis of Moderna, Inc.’s (NASDAQ:MRNA) recent transition is its co-development partnership with Merck.” insidermonkey.com · read source

Industry Drugmakers emerging0.703 independent sources

evidence “Drugmakers Moderna and Merck this summer announced that a cancer vaccine, intismeran autogene, had succeeded in a Phase 3 clinical trial in preventing the recurrence of melanoma, a result experts celebrated as a breakthrough for mRNA-based cancer treatments.” spokesman.com · read source

Industry pharmaceutical companies emerging0.703 independent sources

evidence “The information we have on clinical trial results comes courtesy of pharmaceutical companies Moderna and Merck and hasn’t been officially published yet.” womenshealthmag.com · read source

competitor 4ort Sanofi emerging0.662 independent sources

evidence “Moderna faces intense competition in the vaccine and oncology sectors from established giants like Pfizer (PFE -0.43%), GSK (GSK -1.85%), and Sanofi (SNY -1.58%).” fool.com · read source

competitor 4ort GSK emerging0.662 independent sources

evidence “Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III” aol.com · read source

competitor 4ort Merck emerging0.662 independent sources

evidence “Were you specifically thinking of this Merck-Moderna trial?” news.harvard.edu · read source

Show 3 low-confidence claims

Published, not hidden — scoring low is not a reason to withhold a sourced claim. A contradicted chip means Wikidata holds a different value; both are shown so you can judge.

Founder Robert Langer low0.612 independent sources

evidence ““You have many, many more shots on goal and therefore a much greater chance to succeed,” Moderna co-founder and MIT scientist Robert Langer said via email.” arynews.tv · read source

Headquarters location Massachusetts low0.612 independent sources

evidence “Now working at pharmaceutical company Moderna in Cambridge, Massachusetts, she uses AI to improve manufacturing processes by working out the most promising parameters of an experiment and identifying areas for further investigation.” nature.com · read source

Industry vaccine low0.612 independent sources

evidence “Meanwhile, Moderna stock declined 4.6% after the vaccine maker announced plans for a $2 billion sale of convertible bonds.” livemint.com · read source

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [3] ↑ . lobbyfacts.eu. Retrieved . lobbyfacts.eu. Provenance: wikidata.org.
  2. [4] ↑ . wikidata.org.
  3. [5] ↑ . wikidata.org.
  4. [1] ↑ . wikidata.org.
  5. [6] ↑ . proxy statement. investors.modernatx.com. Provenance: wikidata.org.
  6. [7] ↑ . proxy statement. investors.modernatx.com. Provenance: wikidata.org.
  7. [8] ↑ . proxy statement. investors.modernatx.com. Provenance: wikidata.org.
  8. [2] ↑ . ror.org. Retrieved . ror.org. Provenance: wikidata.org.
  9. [9] ↑ . wikidata.org.
  10. [10] ↑ . proxy statement. investors.modernatx.com. Provenance: wikidata.org.
  11. [11] ↑ . wikidata.org.
  12. [12] ↑ . Fortune.com unicorn list. Retrieved . fortune.com. Provenance: wikidata.org.
  13. [13] ↑ . wikidata.org.
  14. [14] ↑ . wikidata.org.
  15. [15] ↑ . wikidata.org.
  16. [16] ↑ . wikidata.org.
  17. [17] ↑ . wikidata.org.
  18. [18] ↑ . wikidata.org.
  19. [19] ↑ . macrotrends.net. macrotrends.net. Provenance: wikidata.org.
  20. [20] ↑ . macrotrends.net. macrotrends.net. Provenance: wikidata.org.
  21. [21] ↑ . macrotrends.net. macrotrends.net. Provenance: wikidata.org.
  22. [22] ↑ . macrotrends.net. macrotrends.net. Provenance: wikidata.org.
  23. [23] ↑ . macrotrends.net. macrotrends.net. Provenance: wikidata.org.
  24. [24] ↑ . macrotrends.net. macrotrends.net. Provenance: wikidata.org.
  25. [25] ↑ . macrotrends.net. macrotrends.net. Provenance: wikidata.org.
  26. [26] ↑ . macrotrends.net. macrotrends.net. Provenance: wikidata.org.
  27. [27] ↑ . apnews.com. Retrieved . apnews.com. Provenance: wikidata.org.
  28. [28] ↑ . wikidata.org.
  29. [29] ↑ . wikidata.org.
  30. [30] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  31. [31] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  32. [32] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  33. [33] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  34. [34] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  35. [35] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  36. [36] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  37. [37] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  38. [38] ↑ . Form 10-K. sec.gov. Provenance: wikidata.org.
  39. [39] ↑ . Form 10-K. sec.gov. Provenance: wikidata.org.
  40. [40] ↑ . Form 10-K. sec.gov. Provenance: wikidata.org.
  41. [41] ↑ . Form 10-K. sec.gov. Provenance: wikidata.org.
  42. [42] ↑ . Form 10-K. sec.gov. Provenance: wikidata.org.
  43. [43] ↑ . finance.yahoo.com. finance.yahoo.com. Provenance: wikidata.org.
  44. [44] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  45. [45] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  46. [46] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  47. [47] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  48. [48] ↑ . Form 10-K. sec.gov. Provenance: wikidata.org.
  49. [49] ↑ . Form 10-K. sec.gov. Provenance: wikidata.org.
  50. [50] ↑ . Form 10-K. sec.gov. Provenance: wikidata.org.
  51. [51] ↑ . Form 10-K. sec.gov. Provenance: wikidata.org.
  52. [52] ↑ . Form 10-K. sec.gov. Provenance: wikidata.org.
  53. [53] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  54. [54] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  55. [55] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  56. [56] ↑ . annual report. investors.modernatx.com. Provenance: wikidata.org.
  57. [57] ↑ . proxy statement. investors.modernatx.com. Provenance: wikidata.org.
  58. [58] ↑ . proxy statement. investors.modernatx.com. Provenance: wikidata.org.
  59. [59] ↑ . proxy statement. investors.modernatx.com. Provenance: wikidata.org.
  60. [60] ↑ . proxy statement. investors.modernatx.com. Provenance: wikidata.org.
  61. [61] ↑ . proxy statement. investors.modernatx.com. Provenance: wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Moderna. Retrieved November 17, 2026, from https://4ort.xyz/entity/moderna
MLA “Moderna.” 4ort.xyz Knowledge Graph, 4ort.xyz, 17 Nov. 2026, https://4ort.xyz/entity/moderna.
BibTeX @misc{4ortxyz_moderna_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Moderna}}, year = {2026}, url = {https://4ort.xyz/entity/moderna}, note = {Accessed: 2026-11-17}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Moderna — https://4ort.xyz/entity/moderna (retrieved 2026-11-17)

Canonical URL: https://4ort.xyz/entity/moderna · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 12w ago · Trivialist · 2026-08-22 view diff on Wikidata ↗
    HAND ID → 5BEF-4E09-A110-45E5-4525
    "Created claim: HAND ID: 5BEF-4E09-A110-45E5-4525, batch #269254"
  2. 22w ago · Yogithab06 · 2026-06-17 view diff on Wikidata ↗
    Delaware Division of Corporations file number → 6104873
    "Created claim: Delaware Division of Corporations file number: 6104873"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.